• Ridaforolimus: An Assay-First mTOR Strategy

  2026-08-19

  Ridaforolimus (Deforolimus) is examined through an assay-first framework linking mTOR pathway engagement to proliferation, VEGF secretion, apoptosis assay design, and senescence research. The article translates machine-learning senolytic findings into practical decisions for reproducible cancer biology and breast cancer research.

• Biomimetic mRNA Nanovaccines Target Neutrophils in HCC

  2026-08-19

  The reference study presents CMNPs, a cell-membrane-coated mRNA nanovaccine engineered to recognize CD300LD-enriched tumor-associated neutrophils and deliver albumin-fused IL-36γ mRNA. In preclinical hepatocellular carcinoma models, targeted neutrophil activation strengthened antitumor immunity, inhibited tumor growth, and increased survival relative to controls, while also suggesting a practical role for carefully controlled neutrophil preparation in follow-up assays.

• L. gasseri, NR1I3, and E-Cadherin in Colitis

  2026-08-18

  The reference study identifies a mechanistic link between Lactobacillus gasseri ATCC33323 and intestinal barrier protection in DSS-induced colitis. Its central advance is the combination of an intestinal E-cadherin loss-of-function model with transcriptional and in vitro analyses, showing that NR1I3-mediated regulation of CDH1 contributes to the probiotic response.

• YM 58483 (BTP2): From SOCE to Fibrosis Insight

  2026-08-18

  YM 58483 (BTP2) is more than a calcium-entry inhibitor: it is a pathway-level probe for testing how sustained SOCE links immune activation, NFAT signaling, and tissue remodeling. This article connects its established use in T-cell assays with evidence implicating ORAI2-driven SOCE in early postirradiation salivary gland fibrosis, while defining the experimental and translational limits of pharmacologic interpretation.

• 3D Gold Nanocluster Arrays for Reproducible SERS

  2026-08-17

  The reference study introduces polymer pen lithography to fabricate ordered three-dimensional polyethylenimine templates for electrostatic assembly of gold nanoparticle clusters. The resulting substrates combine a reported enhancement factor of 1.67 × 10^7 with an inter-array relative standard deviation below 4.73%, while allowing SERS performance to be adjusted through pattern architecture.

• Tiamulin (Thiamutilin): Research Workflows

  2026-08-17

  Tiamulin (Thiamutilin) connects ribosome-focused antimicrobial testing with cell-based inflammation research. This practical guide covers stock preparation, infection and TNF-α assay design, resistance-aware interpretation, and troubleshooting for veterinary and translational workflows.

• SERT–nNOS Disruption and Fast-Onset Antidepressant Action

  2026-08-16

  The reference study identifies esflurbiprofen as a preclinical fast-onset antidepressant candidate that disrupts the serotonin transporter–neuronal nitric oxide synthase complex in the dorsal raphe nucleus. By combining mBRET-based screening, behavioral models, molecular assays, and resting-state fMRI, the authors connect SERT–nNOS dissociation with altered serotonergic feedback and improved depression-related phenotypes.

• NF 340: A P2Y11 Antagonist for Translational Biology

  2026-08-15

  NF 340 offers a receptor-level way to interrogate purinergic signaling in cancer, immunology, and inflammation research. This article connects P2Y11 blockade with QPRT-driven breast cancer invasiveness, outlines a rigorous validation workflow, and defines the translational limits of current evidence.

• UTP Solution (100 mM) for RNA Assays

  2026-08-14

  Build more consistent transcription, RNA amplification, and siRNA workflows with a prequalified 100 mM nucleotide stock. This practical guide also shows how UTP-supported assay design can help investigate the TRIM66-dependent control of olfactory receptor expression without confusing reagent performance with biological mechanism.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-14

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed for resolving low-molecular-weight proteins and peptides, particularly targets in the 1–10 kDa range. It supports research workflows involving denaturing or non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.

• SGI-1027: DNA Methyltransferase Inhibition

  2026-08-13

  SGI-1027 is a non-nucleoside DNA methyltransferase inhibitor for connecting DNMT blockade with promoter demethylation, tumor suppressor gene reactivation, and apoptosis readouts. This workflow-focused guide covers assay design, handling, comparative advantages, and troubleshooting for cancer epigenetics research.

• 3-Deazaneplanocin (DZNep) Workflow Guide

  2026-08-13

  Build reproducible DZNep experiments around SAHH inhibition, EZH2 depletion, apoptosis, and tumor-initiating cell assays. This guide connects AML, hepatocellular carcinoma, and breast cancer workflow design while emphasizing dose selection, phenotype-specific controls, and troubleshooting.

• Concanamycin A: A Trafficking-Centered Assay Guide

  2026-08-12

  Concanamycin A is a V-type H+-ATPase inhibitor that reveals how organelle acidification shapes autophagy, trafficking, apoptosis, and tumor-cell invasion. This guide connects the compound’s acute pharmacology with a recent ER-exit-site study to improve mechanistic assay design.

• GW 4869 (hydrochloride hydrate) Lab Guide

  2026-08-12

  This scenario-based guide explains how GW 4869 (hydrochloride hydrate), SKU C4769, can improve mechanistic studies of neutral sphingomyelinase, ceramide signaling, and extracellular vesicle release. It covers assay compatibility, DMSO handling, viability controls, interpretation, and practical product-selection criteria.

• HSP90 Regulation of RNA Foci in DM1

  2026-08-11

  Johnson and colleagues used an unbiased small-molecule RNA-FISH screen to identify HSP90 as a regulator of endogenous CUG-exp RNA foci and DMPK mRNA in Myotonic Dystrophy type 1 cells. The study further connects HSP90 activity with p-STAT3 in undifferentiated myoblasts while showing that differentiation reverses the response, emphasizing cell-state-dependent interpretation of RNA-foci assays.

15414 records 1/1028 page Next 12345 下5页 Last page